(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PRECISION MOLECULAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

PRECISION MOLECULAR

ST13

US500000097141177

Class

5

Filing

97141177

Registration

7316899

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

02/27/2024

Trademark type

Combined

Nice classes

5

Filing date

11/24/2021

Registration date

02/27/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/27/2024

Last transaction

02/27/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/12/2023

First use in commerce

12/12/2023

Drawing code

3

Owner type

03

Owner location

Gaithersburg, MD, US

Examiner

FLINT, DANIEL

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "PRECISION" in stylized lettering, with the letter "O" appearing as an aperture design. The word "MOLECULAR" appears under the word "PRECISION".

Holders and representatives

Holders

Precision Molecular Inc.

Representatives

Todd S. Bontemps Potomac Law Group, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic biomarker reagents for medical purposes; molecular imaging and detection agents in the nature of optical and radiopharmaceutical agents for diagnosing and monitoring cancerneurological diseasesneurodegenerative diseases; molecular imaging and detection agents in the nature of optical and radiopharmaceutical agents for providing therapy and radiotherapy to patients with cancerneurological diseasesneurodegenerative diseases

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/27/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/27/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/20/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/19/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/06/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/06/2024

IUAF

USE AMENDMENT FILED

12/15/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/10/2023

EX1G

SOU EXTENSION 1 GRANTED

10/06/2023

EXT1

SOU EXTENSION 1 FILED

10/06/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/06/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/11/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/14/2023

PUBO

PUBLISHED FOR OPPOSITION

02/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/25/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/21/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2022

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

09/14/2022

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

09/14/2022

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

09/14/2022

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

09/14/2022

DOCK

ASSIGNED TO EXAMINER

09/03/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/30/2021

NWAP

NEW APPLICATION ENTERED

11/27/2021

Continuous trademark protection

Get notified about every new filing that threatens PRECISION MOLECULAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.